{
  "name" : "dacemirror.sci-hub.se_journal-article_abb5f168bfde005d7ac1bb6d10d42e0e_zheng2016.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : "Integration of nanomaterials for colorimetric immunoassays with improved performance: a functional perspective",
    "authors" : [ "Wenshu Zheng", "Xingyu Jiang" ],
    "emails" : [ "xingyujiang@nanoctr.cn" ],
    "sections" : [ {
      "heading" : null,
      "text" : "This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication.\nAccepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available.\nYou can find more information about Accepted Manuscripts in the Information for Authors.\nPlease note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains.\nAccepted Manuscript\nAnalyst\nwww.rsc.org/analyst\nView Article Online View Journal\nThis article can be cited before page numbers have been issued, to do this please use: W. Zheng and X.\nJiang, Analyst, 2016, DOI: 10.1039/C5AN02222C."
    }, {
      "heading" : "Analyst",
      "text" : "TUTORIAL REVIEW\nThis journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1\nPlease do not adjust margins\nPlease do not adjust margins\na. Beijing Engineering Research Center for BioNanotechnology & Key Lab for\nBiological Effects of Nanomaterials and Nanosafety, National Center for NanoScience and Technology (NCNST) 11 Beiyitiao, ZhongGuanCun, Beijing 100190 ,China\nE-mail: xingyujiang@nanoctr.cn b. Academy for Advanced Interdisciplinary Studies, Peking University, Beijing c. The University of Chinese Academy of Sciences\nReceived 00th January 20xx, Accepted 00th January 20xx\nDOI: 10.1039/x0xx00000x\nwww.rsc.org/\nIntegration of nanomaterials for colorimetric immunoassays with\nimproved performance: a functional perspective\nWenshu Zheng a,b,c and Xingyu Jiang* a,c\nThe boom of nanotechnology has yielded exciting developments in designing new kinds of colorimetric immunoassays. These nanomaterials-associated immunoassays have shown great potentials for clinical translation and a number of them have already been implemented for testing patient samples from the clinics. Different from most reviews where researchers typically focus on a specific type of nanomaterials or describe assays based on the types of materials, we classify these assays by the function of nanomaterials, focusing on reviewing the distinct phenomenon of nanomaterials and how these properties are utilized to overcome limitations facing traditional colorimetric immunoassays. We also discuss challenges and give our perspectives in this field."
    }, {
      "heading" : "1. Introduction",
      "text" : "Immunoassay has witnessed dramatic progresses in both healthcare and fundamental research since its first description in 1950s. 1 A sensor for immunoassay generally relies on a recognition element such as an antibody to identify the target, and a labeling element to signal the interaction for the readout. The labeling elements in immunoassays can exist in various forms such as enzymes, 2 radioactive isotopes, 1 fluorescent dyes 3, 4 , DNAs 5 or electrochemiluminescent tags 6 , which further give rise to measurable signals. In particular, immunoassays using the colorimetric signal for readout show distinct advances since they can easily accommodate conventional laboratory settings and their signals could sometimes even be detected with naked eyes.\nOne form of the traditional colorimetric immunoassay, enzyme-linked immunosorbent assay (ELISA) that uses a labeled enzyme on antibody to catalyze colorimetric reactions for readout, has become a standard assay for diagnosing many diseases via detecting of biomarkers of proteins, as well as the analysis of many compounds of small molecules. The past half a century has witnessed the great success of ELISA, as well as its continuous evolution and adaption. However, many shortcomings still remain for traditional ELISA (and related assays) in several aspects, including limited sensitivity, complexity in operation, high cost and consumption of reagent. Another popular immunoassay, lateral flow assay\n(LFA) has also been widely applied as another form of traditional colorimetric immunoassay, with gold nanoparticles (AuNPs)-associated LFA being an early example of nanomaterials-associated colorimetric immunoassays. Because LFA is very simple in both operation and readout, it shows distinct advantage in point-of-care (POC) tests. The sensitivity of LFA, however, is typically not comparable to ELISA.\nRecently, the boom of nanotechnology has shed new light on countless traditional techniques including immunoassays. When bulk materials reduce their sizes into nanoscale, many novel phenomena arise. For example, noble metallic nanoparticles showed distinct light absorption and scattering properties, some nanomaterials exhibit catalytic, 7-9 superparamagnetic, 10-12 or fluorescent features 13-16 that do not exist in their bulk form with identical compositions. The large surface area and versatility in surface modification of nanomaterials have proved useful in biomedical application. 17- 19 Benefiting from the advances in chemistry and materials science, different kinds of nanomaterials that exhibit desired properties can now be easily prepared and functionalized. 17, 20- 23 These nanomaterials are becoming useful in biosensing; 24, 25 with many enhanced colorimetric immunoassays being developed, aiming at overcoming several limitations facing traditional ELISA or LFA.\nSince most reviews have either focused on a specific set of nanomaterials or classify assays by the different types of nanomaterials used 23,25-27 , we classify assays into the following three sections according to different working principles and the functions of nanomaterials in these assays, we divide our discussion: 1. Nanomaterials serve as colorimetric transducers in immunoassays; 2. Nanomaterials mimicking traditional enzymes or serving as enzymes via cascade reactions; 3. Nanomaterials used to enrich and amplify the signal. In each section, we discuss the functions of nanomaterials with the representative work, followed by several most recent works\nPage 1 of 13 Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins\nthat illustrate the advantages and limitations of such assays. We give special notes to these that have applied in clinical samples because they show promises in clinical translation. We chose this arrangement because we wish to focus on why and how analytical scientists would introduce nanomaterials into colorimetric immunoassays. Moreover, in this organization we could systematically discuss the properties and functions of nanomaterials which truly benefit these assays; we are also able to pay our attention to how a new method is built based on nanomaterials, we suggest the methodology is very important because once a new method is developed, it can apply to many different types of targets by simply tuning its recognition element. We hope this organization may inspire both scientists in materials to contribute novel materials and analytical chemists to develop new approaches in this field.\nIt should be noted here some examples in this review have incorporated multiple nanomaterials with different functions, while we discuss these assays across the above five sections instead of giving an individual section for them. To avoid confusion in reading we herein give a list of these works (Table 1). Because of the limitation of space, we have only selected a few most representative papers in each category."
    }, {
      "heading" : "2. Nanomaterials-associated immunoassay",
      "text" : ""
    }, {
      "heading" : "2.1. Nanomaterials serve as colorimetric transducers in immunoassays",
      "text" : "Nanomaterials possess distinct optical properties compared to bulk materials. For example, some noble metal nanomaterials such as gold nanoparticles (AuNPs) and silver nanoparticles (AgNPs) exhibit ultrahigh molar extinction coefficient, which could be several orders of magnitude higher than those of common dyes. In addition, a widely studied and applied optical property arise at the nanoscale is called localized surface plasmon resonance (LSPR). LSPR is a result of the interaction between the local plasmons across the surface of nanomaterials and incident light. The LSPR spectrum of nanostructures is strongly influenced by their size, shape and the inter-particle distances. Recently these properties have been\nintensively applied in developing colorimetric immunoassays with different formats. 2.1.1 Incorporation of nanomaterials to mimic “enzyme targets” in traditional ELISA A prominent merit of colorimetric immunoassays is that their convenient readout shows promises for POC assays. In traditional ELISA, the enzyme catalyzes chemical reactions of chromogenic substrates and triggers the appearance of the color of the solutions, which can be directly observed with naked eyes. However, in many routine clinical diagnostics, the significant concentrations of analytes are often not sufficiently high to generate a distinguishable signal for naked eye readout. Typically, in order to form a meaningful result of diagnostics, the changes in the hue or intensities of colors of the solution need to be quantified by measuring the absorbance with a spectroscopy or a plate reader. 28 Improving the sensitivity for traditional ELISA thus has been crucial for developing ultrasensitive naked-eye based assays. Developing new kind of “enzyme targets” is an appealing solution for this objective for the following reasons: i) according Lambert-Beer law, the limit of detection (LOD) for the traditional ELISA is limited by the molar coefficient of the chromogenic substrates; ii) the traditional ELISA varies its optical signals by tuning the shade of the colored product, which is difficult to distinguish between samples with the same color, since human eyes are more sensitive to seeing the color changes than the changes in shade of a color. 29\nThe diverse surface chemistry and the novel optical properties of nanomaterials make nanomaterials perfect candidates for design such new “enzyme targets”. In a nanomaterials-associated immunoassay, nanomaterial can be designed to shift their LSPR spectrum specifically to the enzyme labeled on antibodies in traditional ELISA. The shift in LSPR spectrum of nanomaterials would generate a colorimetric signal which can be read with a UV-Vis spectroscope, sometimes there may be obvious changes in both intensity and color of the optical spectrum of nanomaterials for naked-eye based readout. Herein, given the different signal generation principles we discuss two types of immunoassays that use nanomaterials to mimic “enzyme targets”: inter-particle distance based assays and size/morphology-dependent assays. Inter-particle distance based assays. The inter-particle distance dependent optical properties of nanomaterials have been widely applied in colorimetric assays. For example, AuNPs can be designed to aggregate in the presence of the targets, to show a pronounced color change from red to blue/purple that can be observed with naked eye 30 . AuNPsaggregation based assays have been widely applied for the sensing of a variety of analytes, including metal ions, 31-33 small molecules, 34, 35 macromolecules 36 or living cells 37-39 with unprecedented sensitivity for naked-eye based detection. Similarly, colorimetric immunoassays using nanomaterials as “enzyme targets” also exhibits enhanced performance in sensitivity. Needless to say, to design such systems, the first task is to design nanomaterials as “targets” that are sensitive to the labeling element of ELISA, the enzyme.\nTable 1 Assays that have incorporated several nanomaterials with different functions\nRef Enzyme Mimics Colorimetric transducers Enrichment 41 AuNPs MBsa 44 AuNPs MBs 45 AgNPRb MBs 79 CuO NPsc AuNPs 80 83 106 CuO NPs Fe3O4 NPs d AuNPs AuNRs Fe3O4 NPs Fe3O4 NPs 108 Fe3O4 NPs Fe3O4 NPs AuNPs a. Magnetic Beads; b. Silver nanoprisms; c. Copper monoxide nanoparticles; d. Ferroferric oxide nanoparticles; e. Gold Nanorods.\nPage 2 of 13Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "Journal Name ARTICLE",
      "text" : "This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3\nPlease do not adjust margins\nPlease do not adjust margins\nWe developed AuNPs that specifically respond to acetylcholinesterase (AChE) (Fig. 1a) via surface chemistry. 40 AuNPs were modified with Rhodamine B via electrostatic interactions. After the addition of both AChE and acetylthiocholine (ATC, an analogue of acetylcholine), AChE could catalyze the reaction from ATC to thiocholine. The thiocholine would then competitively replace the Rhodamine B absorbed on the AuNPs, causing the aggregation of AuNPs via electrostatic interactions and, triggering a color change of the solution. Using this AuNPs to mimic the “targets” for AChE in a traditional ELISA, an immunoassay was further developed for the ultrasensitive, naked eye detection of pathogens in patient serum samples, 41 which yields a comparable sensitivity to polymerase chain reactions (which is typically several orders of magnitude higher than the capabilities of immunoassays).\nAuNPs-aggregation type assays can be compatible with conventional ELISA, which typically either employs alkaline phosphatase (ALP) or horseradish peroxidase (HRP) as the labeling enzymes for readout. However, most early studies using nanoparticles as colorimetric readout rely on the labeling of enzymes other than ALP or HRP on antibodies, thus limiting their adoption to conventional platforms. To overcome this limitation and apply the AuNPs-based colorimetric readout for an ALP-based immunoassay, we turned to an AuNPs-based method that our group developed for detecting copper ions 42 . Via carefully designed chemical reaction, we succeeded in\ntransforming the AuNPs in the Cu detection system to a highly selective for ALP (Fig. 1b), which was further implemented in colorimetric immunoassay. 29 The ALP labeled on second antibody hydrolyzed the dephosphorylation of ascorbic acidphosphate, generating a reductive ascorbic acid that transformed Copper (II) into Copper (I). Benefitting from the highly selective Cu (I)-catalyzed azide/alkyne cycloaddition (CuAAC), azido and alkyne functionalized AuNPs aggregated specifically in the presence of monovalent copper ions, 42 which further triggered the aggregation with pronounced color change. This assay offered order-of-magnitude improvement in the LOD for rabbit anti human IgG than conventional ELISA, and was successfully applied in patient samples for testing of IgM of mycoplasma pneumonia with improved accuracy compared to ELISA based on para-nitrophenol phosphate. Size/morphology-dependent assays Besides the optical property-dependence on interparticle distance, another attractive optical feature for metal nanomaterials is their size/shape-dependent light absorption. In an aqueous solution, the physical changes in the structures of nanomaterials give rise to the dramatic shift of their LSPR spectrum which results in the change of solution colors, thus an ultrasensitive colorimetric immunoassay could be developed if the enzyme would catalyze the structural change of the nanomaterials. Recently, several ultrasensitive immunoassays based on enzyme-controlled growth of nanoparticles were proposed. 43 One example is illustrated in\nFig. 2a, 44 anti-PSA (prostate-specific antigen) antibodies immobilized on the magnetic beads were conjugated with glucose oxidase (GOx). In the presence of PSA, the GOxantibody-MB conjugates can be absorbed on the polystyrene substrate via a sandwich assay; consequently, GOx catalyzed the oxidation of glucose to generate H2O2, which further induced the growth of 5 nm AuNPs after the addition of AuCl4 - . The strong light absorbance of 5 nm AuNPs then resulted in the color change of the solution which is in proportion to the concentration of analytes. The naked-eye LOD of this assay for PSA was as low as 60 fg/mL. Moreover, this assay can accurately quantify PSA in patient serum (Fig. 2b), while commercial HPR-based ELISA failed to correctly assay 2 out of 9 samples (Fig. 2c). This improvement in performance mainly comes from the fact that the moderate LOD of HRP-based ELISA may not have sufficient sensitivity for the clinical concentration of PSA in certain patient serum, while the nanomaterials-assisted ELISA that exhibits enhanced sensitivity would be more beneficial.\nIn contrast to particle-growth based assays, etching nanomaterials were also used to develop ultrasensitive assays. For instance, it was reported that silver nanoprism could be etched by hydrogen peroxide, 45 which was used to detect PSA (Fig. 3). 46 In this approach the detection antibodies were conjugated with GOx and immobilized on the surface of immunomagnetic beads. After capturing the analytes in a sandwich assay, the presence of GOx would catalyze the glucose to generate H2O2. As a result, silver nanoprisms were etched into nanodiscs, simultaneously, a blue-to-purple color change could be observed. The naked-eye LOD of this assay\nFig.1 (a) AuNPs can be triggered to aggregate in the presence of AChE. (Reproduced from ref. 41 with permission from Willey-VCH). (b) The aggregation between alkyne-AuNPs and azide-AuNPs is triggered with the ALP-labeled antibody via chemical cascade reactions (dephosphorylation lead to the ascorbic acid that can reduce Cu (II) to Cu(I). (Reproduced from ref. 29 with permission from the American Chemical Society).\nPage 3 of 13 Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "4 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins\nwas 10 fg/mL for PSA. In addition, this assay showed a broad\nlinear range between 10 fg/mL and 100 pg/mL. Moreover, this method was applied with serum samples from suspected cancer patients. The aforementioned size/morphologydependent assays show robustness in sensitivity, but they may require several washing steps and relatively complex operation. As a result, they are suitable in these areas where large instrument are limited, while ultra-sensitive detection of trace amount of target are urged. Beside, several potential factors that may influence their detection performance such as pH or ionic strength still remain to be studied. 2.1.2 Nanomaterials as colorimetric label in lateral flow assays ELISA need run multiple steps with repeated addition and removal of reagents at given time point before the signal coming out. To overcome the complex operation, AuNPsassociated LFA has emerged as a robust method that endows POC assays (without washing steps, but allows for immunoassays) for analytes in complex samples. In a typical AuNPs-based LFA, reagents are immobilized and simply allowed to dry on different regions of the test strip which is often made from porous materials such as cellulose. The liquid samples are added to the sample region and migrate on the substrates via capillary interaction. During the migration process, analytes in the sample would interact with antibodylabeled AuNPs in the conjugate region, followed by capturing with immobilized antibodies on the test line. An obvious red line is thus generated due to the LSPR of aggregated AuNPs. In the LFA, the high extinction coefficiency of AuNPs allows for the generation of colorimetric signal at low concentrations of\nnanoparticles, and the enzymes are no longer needed. Until\nnow, most naked eye-based diagnostics in practice rely on the integration of LFA, with the pregnancy test strip as a widely commercialized example.\nFig.3 GOx-catalysed etching of triangular silver nanoprisms (AgNPRs) for assaying PSA with ultra high sensitivity; the color change is in proportion to the concentration of PSA. (Reproduced from ref. 46 with permission from Elsevier).\nFig.2 (a) Schematic diagram of GOx-catalyzed growth of AuNPs for assaying PSA with ultra high sensitivity; PSA concentrations of the serum from 12 prostate cancer patients and 5 healthy individuals are evaluated using AuNPs-based assays. (b) and HRPbased ELISA(c). (Reproduced from ref. 44 with permission from the American Chemical Society).\nPage 4 of 13Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "Journal Name ARTICLE",
      "text" : "This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5\nPlease do not adjust margins\nPlease do not adjust margins\nDespite the advances such as being instrument-free, easy operation and naked eye readout, LFA is not comparable with ELISA in term of sensitivity. To address this issue several different signal amplifying strategies are proposed in recent years. 47-49 For example, a signal amplification strategy was designed by using 2 kinds of antibody-labeled AuNPs with different size as detection probes (Fig. 4). 49 To enable the naked-eye detection of E.coli, the sample that contains E.coli was first incubated with the anti-E.coli O157:H7 modified AuNPs (first AuNPs probe), and anti-mouse-AuNPs (second AuNPs probe), followed by addition to the sample pad of the LFA. These two probes and E.coli formed complex and further absorbed with Anti-E.coli O175: H7 antibodies which were precoated on the test line. In this assay the first and second AuNPs probes with different sizes combinations were systemically studied to improve the sensitivity. With the optimized combination, a naked eye LOD for E.coli as low as 1.14*10 3 CFU mL -1 in milk samples was achieved, which is 100- fold lower than traditional LFA. However, in these signal amplification strategies, several washing and incubation procedures were added, which would bring complications than traditional LFA.\nLFA also suffer from inability to provide quantitative information. A report has enabled the semi-quantitative LFA by spotting the antibody in a pattern manner instead of a straight line. 50 Another frustration is that false positive and false negative results frequently occurred in a LFA, which is attributed to variation of the materials from what these substrates are made. 51 The flow speed also has important influence on the testing, generally a high capillary flow speed would give rise to the high specificity, but the low sensitivity. 52 Currently the only solution is carrying out comprehensive parameter optimization when developing a LFA for new targets. As mentioned above, the continuous improvement of sensitivity and specificity for LFA would still be the critical topic in the coming years. Developments of nanomaterials with robust stability would be the most urgent demand; the standardization of nanomaterials preparation would also be very beneficial.\n2.1.3 Refractive index change surrounding nanostructure based assays. The LSPR spectrum of nanostructures is affected not only by their sizes, shapes and interparticle distances, but also by the refractive index of the medium surrounding them. As the result, in an immunoassay if a target molecule in solution is recognized by the capture probe to immobilize on the surface of the nanostructures the local refractive index would change to result in a colorimetric signal. This phenomenon has proved useful for probing bio-molecular interactions. In the following section, we discuss: i) immunoassays based on measuring transmitted spectrum are referred to as LSPR-based colorimetric immunoassays; ii) assays based on measuring scattered light are referred to as dark field colorimetric immunoassays. LSPR based immunoassays LSPR based assays are very closely related to the surface plasma resonance (SPR) techniques which have been already developed for a few decades. Both assays rely on the fact that a detectable signal can be measured due to the changes in the refractive index near metallic surfaces. SPR assays, as a much more mature technique, have been widely applied as a highly sensitive tool for probing bimolecular integrations. The refractive index sensitivity of SPR sensors is about 4 orders of magnitude larger than that of LSPR assays, giving rise to the fact that LSPR assays can hardly achieve the LOD obtained with SPR assays. 53 However, LSPR assays still attract considerable attention because they show several inherent advantages. For example, a standard SPR assay employs the reflectivity of a planar surface for detection, while in a LSPR assay the transmissivity are measured, which accommodates simple and standard optics. In LSPR assays, signals can be generated in a wide range of incident angles. Since LSPR assays are more sensitive to the local rather than bulk refractive index changes, they show a higher spatial resolution compared to SPR assays. 54 In addition, the sensing volume could be greatly reduced in a LSPR assays. A pioneering LSPR assay was reported in 2002 by using the biotin-streptavidin as model system, 55 in this approach COOHfunctionalized AuNPs were immobilized on the surface of NH2functionalized glass surface via electrostatic forces, and then\nFig.4 Dual AuNPs based LFA for the detection of E.coli with enhanced sensitivity. (Reproduced from ref. 49 with permission\nfrom Elsevier)\nPage 5 of 13 Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins\nAuNPs were further modified with biotin through a linker, the interaction between biotin and streptavidin near the surface of AuNPs allowed for a LOD of 0.83 nM for streptavidin. Since their first report, many different nanostructures such as nanostars, nanorods, nanocrescents and nanodecahedra 56-59 have been reported to be able to serve as LSPR sensors. In order to implement LSPR immunoassays in physiological fluids or tissues samples, the signals must have a good permeability as well as being able to be distinguished from sample interference. This means that LSPR spectrum in such assays for signal readout should be best performed in the region of >700 nm. For this purpose a LSPR assay that could be implemented in the serum samples was developed by employing gold nanorods (AuNRs) whose LSPR spectrum can be tuned at the near-infrared region (700-1300nm). 60 In this assay the surface of these AuNRs were modified with biotin, after capturing streptavidin from the samples, concentration-dependent LSPR changes were observed. This approach gave a LOD of 5 ng/mL in PBS, and this assay was able to operate in serum samples. A similar report that uses silica-gold core shell structures was able to detect streptavidin in whole blood samples without any complex pretreatment. 61 These assays thus improve the sensitivity of detection in human whole blood or serum sample.\nTo improve the sensitivity of LSPR assays, a number of\nworks have made some progress. Recently an assay for signal amplification with a different approach was developed, after target binding, HRP labeled on the target would catalyze local precipitation reaction around the particle surface, which greatly amplified the LSPR shift. 62 With advanced imaging settings this assay was able to detect the presence of even one HPR on one particle. The drawback of this assay is that it is not label-free, which is typically the greatest benefit of LSPR assays over other types of immunoassays. Besides the efforts on experimental design, research on data analysis has helped to improve the sensitivity. In most reported LSPRs assays the shift of peak intensity or position are usually used for quantification, while a recent research proved that when evaluating the response by utilizing the shape change of LSPR spectrum, both signal-to-noise ratio and reliability are greatly enhanced in LSPR based assays. 63\nOne key step for preparing LSPR sensors is immobilizing nanostructures on a bulk surface such as glass. Even though different surface immobilization techniques have been developed, 64-66 poor adhesion still remains tough problems for LSPR assays. To address this issue, nanolithography have been developed as an inexpensive, simple, high-throughput nanofabrication technique to prepare well-ordered 2D nano array with tunable parematers 67 . Followed by the pioneering work, this technique have been intensively studied to\nFig 5. (a) Chemical modification of antibody on AuNPs embedded-glass for LSPR immunoassay. Interaction between IgG and Anti-IgG would generate a colorimetric LSPR signal. (Reproduced from ref. 71 with permission from The Royal Society of\nChemistry). (b) Principle of dark field microscopy. (Reproduced from ref. 72 with permission from Elsevier). (c) Fabrication of\nAuNR-coated substrates for dark field immunoassays. (Reproduced from ref. 78 with permission from The Royal Society of Chemistry). (d) Spectra of an AuNR at different stages; set: the dark field image of the selected AuNR after target binding.\n(Reproduced from ref. 78 with permission from The Royal Society of Chemistry).\nPage 6 of 13Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "Journal Name ARTICLE",
      "text" : "This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 7\nPlease do not adjust margins\nPlease do not adjust margins\ninvestigate the size-related properties of nanomaterials and to develop high-performance LSPR sensors. 68, 69 More recently, another effective method for fabricating the large scale, stable LSPR devices was developed. 70 AuNPs could form and physically embed in a glass surface after irradiating a series of gold films with different thickness under microwave plasma. In this approach the size and distance can be easily controlled, and these nanoparticles were stable against immersion in ethanol and adhesive tape test. They further developed an LSPR assay using this substrate, by using IgG as a model system, bimolecular interactions happened at the interstices rather than at the surface of AuNPs were probed (Fig. 5a). 71 Dark field colorimetric immunoassays Recently, dark field microscopy has been combined with nanomaterials to develop the high spatial resolution techniques. These approaches also benefit from the LSPR properties of nanomaterials. A typical dark field microscopy is illustrated in Fig. 5b. 72 After passing through a dark field condenser that only allows light with high angles to pass, white light are focused at the samples, due to the LSPR effect, a strongly enhanced scattering by nanostructures is induced. The scattered light is then recorded with a true color CCD or a spectrometer CCD. Dark field technique combined with LSPR has developed diverse applications such as cell imaging, 73 observing chemical reactions, 74 probing nanoparticles 75 and biosensing. 76, 77 For instance, an immunoassay was performed with a dark field microscopy and AuNRs. 78 The sensor was fabricated by coating a glass with AuNRs which were further functionalized with a capture antibody (Fig. 5c). Spectrum change could be observed after antibody labeling and target binding (Fig. 5d). Using this approach, detection of neutrophilgelatinase associated lipocalin, a biomarker for kidney disease, was achieved with a LOD at 8.5 ng/mL. This approach is also capable of detecting neutrophilgelatinase in human blood or serum samples. The primary advantage of dark field immunoassays is that it achieves ultra-high spatial resolution which is down to single nanoparticle. The disadvantage of dark field immunoassay is that it relies on much more complex and costumed optical settings.\nCompared to the traditional ELISA, the most attractive feature for the refractive index change based assays is being label-free, so these assays show superiority when the labeling process may sacrifice the activities of natural behavior of recognition probes in an immunoassay. Currently, a general defect for these assays is their reliance on instrument, which limits their application in POC tests. We suggest that developing miniaturized and personalized devices that achieve these assays is worth pursuing in order to make them more generally applied. 2.2 Nanomaterials mimic the traditional enzyme or serve as the enzyme via cascade reaction In a traditional ELISA, efficiency of the catalytic reaction is sensitive to the activity of natural enzymes. These enzymes may suffer from inactivation/degradation during storage and transport. Besides, natural enzymes are costly in preparation and purification, and generally they also need to be stored at low temperature to maintain their activity.\nTo address these issues, we developed a natural enzymefree immunoassay by using copper monoxide nanoparticles (CuO NPs) as enzyme mimics that enabled the ultrasensitive detection of a HIV biomarker (Fig. 6a). 79 In this assay the antigen was first incubated and blocked in the micro plate, followed by recognition with primary antibody and second antibody successively. Different from traditional ELISA where the second antibody was labeled with enzyme, in this approach the second antibody was labeled with CuO NPs to mimic enzymes for triggering the colorimetric signal, upon the addition of HCl and reducing agents such as sodium ascorbate, Cu 2+ was released and reduced into Cu (I). Cu (I) could trigger the aggregation of AuNPs as a result of CuAAC reaction between alkyne and azido groups on the surface of AuNPs 42 , giving rise to the red-to-blue color change of the solution. This assay provides a naked-eye LOD which is compared to instrument-based systems. As a practical application, this assay can detect HIV biomarkers in patient serum samples, where many interfering molecules co-existed. In this approach, This report has opened a new door for highly sensitive indirect immunoassays that is based on detecting the concentration of metal ions. For example, a method that used CuO NPs for the signal generation was also reported to detect a cancer biomarker (α-fetoprotein) in patient serum samples. 80\nThese nanomaterials-based assays are based on specially designed chemical cascade reactions, which cannot\nFig. 6 (a) A colorimetric immunoassay based on the CuOlabeled antibody. CuO nanoparticles are dissolved to release copper ion that trigger the aggregation of AuNPs via click chemistry, resulting in a red to blue color change. (Reproduced from ref. 79 with permission from Willey-VCH). (b) Synthesis and modification of Pt@SiO2 nano enzyme, the Pt@mSiO2-protein conjugates show HRP-like activities. (Reproduced from ref. 97 with permission from Elsevier).\nPage 7 of 13 Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "8 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins\naccommodate the natural enzyme substrates. Over the past two decades, a number of works have reported nanomaterials with natural enzyme activities, many nanomaterials such fullerene, noble metal particles and magnetic nanoparticles have been prepared to exhibit enzyme-like activities with different mechanisms. These enzyme-like artificial nanomaterials were often named “nanozymes” in some literatures. 81,82 Herein, we discuss examples of integrating nano enzymes for colorimetric immunoassays.\nHorseradish peroxidases (HRP) is one of the most widely used enzymes for colorimetric immunoassay, surprisingly, in 2007 the HRP-like activities of Fe3O4 nanoparticles was observed 83\n, in this work Fe3O4 nanoparticles of three different\nsizes could all catalyze different HRP substrates including TMB, DAP and OPD into their corresponding products, indicating the potential of using Fe3O4 nanoparticles as enzyme mimics in colorimetric immunoassays. It was also observed that the catalytic activity depends on the sizes of nanoparticles, where smaller ones exhibited higher activity. Followed by this study, Fe3O4 nanoparticles were used as nanozyme to develop an assay for hepatitis B virus surface antigen. Using Fe3O4 nanoparticles instead of HRP in the immunoassay shows several advantages: i) they are easy to prepare and inexpensive; ii) besides the catalytic activity, the natural magnetic property of Fe3O4 enables the enrichment and pretreatment of analytes, giving rise to improved sensitivity; iii) unlike natural enzymes, these nano enzymes retain their activities after storage over a wide range of temperature and pH.\nAfter this pioneering work, a significant amount of materials with different composition and morphology such as CuO NPs, AuNPs, Au nano clusters, Co3O4 NPs, Carbon nanotubes, Au@Pt nanorods have reported to exhibit similar activities as different enzymes. 84-88 Moreover, a significant amount of nanomaterials that serve as enzyme mimics are utilized to develop colorimetric immunoassays for different targets, 89-93 Several reviews have also been wrote for the detailed discussions including mechanisms and applications of these nanoenzymes. 94,95,96 Even being not very clearly understood, it is proposed that different nanozymes may have different mechanisms in catalyzing the enzymatic reactions. For example, as peroxidase mimic, a Fenton reaction is proposed response for the activity of iron oxide nanoparticles, 97 while the ability for electron transfer between the substrates and H2O2 instead of hydroxyl radical is suggested for the activity of Co3O4 NPs. 98 In the case of AuNPs as nanozymes, the activities may even attribute to either the Au core or the ligands present on the surface of AuNPs. 96 We believe a further understanding out these nanozymes would be very beneficial in developing novel and efficient nanozymes.\nEven though the nanozymes have attracted great attention in recent year, several challenges of nanozymes remain to be overcome for their practical applications, including: i) the catalytic efficiency of nanozymes is typically not comparable to these of natural enzymes; ii) the adsorption of exogenous molecules on the surface of nano enzymes would compromise\ntheir activities; iii) in order to maintain a stable performance, nano enzymes must also have good dispersion stability in complex samples. To address these issues, one peroxidase-like nanozyme (Fig. 6b) with appealing stability and high catalytic efficiency was developed and utilized to develop a colorimetric immunoassay. 99 In this work, a platinum (Pt) core that exhibit catalytic activities was encapsulated within mesoporous silica, and the surface of the silica was functionalize with a NH2 group and further modified with O,O'-bis [2-(N-succinimidylsuccinylamino)ethyl] polyethylene glycol (NHS-PEG-NHS) giving rise to easy conjugation of antibodies via NHS chemistry. Because of the protection provided by the silica shell, the modification of antibodies would have a negligible influence on the catalytic activity of the Pt core. In addition, such nano enzymes also exhibit good stability in buffer saline as a result of the capping PEG. These nanozymes were employed to detect human chorionic gonadotropin (HCG, a biomarker important for detecting early-stage pregnancy) in a sandwich assay. Unfortunately, even with a better sensitivity than most nanozymes-based assays, the detection limit in this approach is still not comparable to that of HRP-based immunoassays. Thus, the continued development of nano enzyme with high efficiency would still be a critical topic in this field for the several years to come. This field is worth pursuing because once the efficiencies of nanozymes is comparable to natural enzymes, it would be revolutionary to traditional ELISA by reducing the costs in both mass-production and shortage of these labeling elements for ELISA to trigger the signal. 2.3 Nanomaterials used for enrichment Nanomaterials exhibit a number of distinct physical properties over bulk materials. Among them the magnetic property of nanomaterials are frequently studied and applied in analytical and biomedical applications. 100 As the most representative magnetic nanomaterial, magnetic nanoparticle have been proved to be very useful tool for the capture, enrichment and separation of analytes of many types, such as cells, proteins and DNAs from complex biomedical samples. 101\nCurrently, many kind of magnetic nanomaterials can be prepared in laboratory, with the Iron oxide nanoparticle being the most common employed nanomaterials for separation in analytical techniques. The use of magnetic nanoparticles (MNPs) is ideal in immunoassay because most targets in immunoassays have no naturally occurring magnetic proprieties, making it possible to enrich targets with great specificity and low background noise. 10 Moreover, these MNPs can be easily separated and controlled in a magnetic field. For example, in a recent research MNPs are modified with capture probes. After the binding events, these MNPs were separated and analyzed with mass spectrometry for assaying the targets. 102 Some other features of magnetic materials are also synergistically utilized to develop diverse kinds of sensors such as giant magneto resistive sensors, 103 electrochemical sensors. 104 MNPs could also be employed in magnetic resonance imaging as it is approved by the U.S. Food and Drug Administration. 105\nIn a colorimetric immunoassay, MNPs could be modified with antibodies to capture the antigen, the captured antigen\nPage 8 of 13Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "Journal Name ARTICLE",
      "text" : "This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 9\nPlease do not adjust margins\nPlease do not adjust margins\nthen were enriched in the magnetic field simply with a magnet, followed by readout with a signal generation probe such as enzyme-labeled second antibody. This principle has already been widely applied in routine clinical diagnostics and fundamental research. There are several distinct advantages of MNPs over magnetic micro/macroparticles: i) nanoparticles with small size have a larger surface to volume ratio, they can thus carry relatively large amount of molecules for recognition (like an antibody) ; ii) The size of nanoparticles is comparable to the targets, which enables the rapid diffusion to complete the reaction in a short period of time; iii) MNPs exhibit super paramagnetic properties (i.e., they are only magnetic in the presence of an external magnetic field) when their sizes is smaller than 30 nm, allowing nanoparticles to be free from aggregation without the presence of external magnetic field.\nMNPs have been also used to improve the performance of LSPR based assay, for example, in a recent study, the author have used the antibodies functionalized magnetic nanoparticles to capture and enrich cardiac troponin I (cTnI) from the human blood samples via magnetic force, followed by mixing them with antibodies functionalized AuNRs. As a result, the binding between capture antibodies on the surface of AuNRs and cTn l would bring the MNPs to the surface of AuNRs and an enhanced LSPR shift would be generated for assaying cTn I. 106 The improved sensitivity in this approach is attributed to the following reasons: The high refractive index and high molecular weight of MNPs would enhance the LSPR shift of AuNRs, which is known to be highly sensitive to variations in the localized refractive index near the surface of the nanostructures. The high surface-to-volume ratio ensure the high binding density. Moreover, the magnetic proprieties enables the pre-concentration of the target.\nEven though MNPs have been successfully applied to enrich analytes in many researches and commercialized products such as ELISA kit, several challenges still remain\nespecially for their applications in analytical field. Due to their small sizes, to precisely manipulate these nanoparticles, sufficiently high magnetic forces are required. The functionalization of nanoparticles may have a more serious effect on their magnetic activities than that of micro/macroparticles; moreover, the modification might sacrifice the stability of nanomaterials, when presented in complex samples, the nonspecific interaction might result in irreversible aggregation of MNPs, which is bad for immunoassays or diagnostics. We suggest that the inventions of magnetic nanomaterials with stable magnetic activity, easy synthesis, good dispersibility and stability would be the most exciting breakthroughs waiting to take place in this area.\nNanomaterials can be also used to enrich enzymes to improve the readout signal. Usually in a traditional ELISA, a recognition probe such as a second antibody binds to only one enzyme, if more enzymes could be integrated with only one recognition probe, the sensitivity of an immunoassay would be greatly improved. Many nanomaterials have a large specific surface area; in addition, nanomaterials of different kinds can be easily functionalized with diverse chemistries. These properties endow nanomaterials the ability to serve as enzyme carriers for signal amplification in immunoassays. For example, magnetic beads that carried antibodies and enzymes were designed for colorimetric signal amplification (Fig. 7a). 41 NHydroxysuccinimide (NHS) activated magnetic beads were surface modified with AChE (the enzyme to generate the colorimetric signal) before these magnetic beads were conjugated with antibody via copper-free click chemistry. In this assay, a target was first captured with the antibody that had been immobilized on the surface of the polystyrene (PS) plate, and then recognized by Ab2 (Second antibody)-AChE-MB conjugates which carried more than one enzyme to further trigger the color change. As a result, trace amount of the analytes could be detected with enhanced colorimetric signal. Some other nanomaterials, such as AuNPs can also be used as enzyme carriers. Compared to magnetic beads, the surfaces of AuNPs are easier to modify with proteins due to the strong AuS interaction. For instances, AuNPs have been applied as HRP carriers for colorimetric immunoassay for carcinoembryonic antigen with a detection limit of 48 pg/mL. 107 In a recent report, two kinds of different nanomaterials were employed to enrich both antibodies and targets to develop ultrasensitive detection of PSA (Fig. 7b). 108 In this approach magnetic beads were used to capture, separate, and enrich the target, while AuNPs were used as catalase carriers to catalyze colorimetric reaction. Benefitting from two rounds of signal amplification, the detection limit for PSA in this assay was as low as 30 pg/mL. This approach was applied for assaying PSA in clinical serum samples, with identical result to these obtained from commercially ELISA. The advances of AuNPs over MNPs is their diverse surface chemistry allows easy modification. However, they do not propose the magnetic properties which is efficient in isolation and separation. We herein suggest that some AuIron oxide core-shell structures that exhibit dual functions could be further utilized in this field. Fig.7 (a) Preparation of magnetic nanoparticles-antibodyenzyme conjugates; Antibody-labeled magnetic core can be used for sample pretreatment and the load enzyme enables a stronger catalytic efficiency. (Reproduced from ref. 41 with permission from Willey-VCH). (b) Colorimetric Immunoassay combining magnetic beads (MBs) and AuNPs. MBs can be used for target pre-concentration and AuNPs are used as enzyme carrier. (Reproduced from ref. 108 with permission from the American Chemical Society).\nPage 9 of 13 Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "10 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins"
    }, {
      "heading" : "3. Discussions and Perspectives",
      "text" : "Above we have discussed different strategies of integrating nanomaterials for colorimetric assays, compared to traditional immunoassays, each of them shows distinct advantages and limitations. Ideally, a perfect colorimetric immunoassay should be highly sensitive and selective, inexpensive, easy to operate and enzyme/label-free. Such an assay that share all these desired features is currently unavailable. Besides efforts on the continuous development of these assays, we suggest that a more efficient way is to perform an existing assay in the case of the practical needs. For instance, pregnant women have very high HCG levels, so a pregnancy test does not necessarily require the ultrasensitive assay which may complicate the operation, a LFA that are facile and simple would be just enough; the label-free assays mostly rely on the aid of instruments which is not suitable for the in situ detection, while they show unparalleled superiority when the recognition probe is difficult to be conjugated with labeling elements. In order for the selection of the most suitable assays for given analytes, as well for the further development of these assays, we herein give a concise comparison of most outstanding features for these aforementioned assays (Table. 2).\nDespite the individual features, a general disadvantage for all the nanomaterial-associated assays is that their reproducibility and stability are less than traditional assays. This can be attributed to both experimental and systemic factors. Currently most nanomaterials are generated from laboratories, unlike bulk materials, homogeneity of nanomaterials vary from many environmental and human factors. This issue should not be a hurdle for building a method using nanomaterials, because the development in industrial technology would finally ensure the standardization of the production of nanomaterials. In addition, due to large specific surface area, the nonspecific adsorption of interfering agents often occurs on the surface of nanomaterials in biological samples. Although antifouling agents like polyethylene glycol\n(PEG) and bovine serum albumin can resist surface fouling, many challenges still remain. For example, PEG suffers from auto oxidations in biological samples and thus may not be sufficiently long-lasting for commercial diagnostic kits. We believe that special attention of the future efforts should be paid to improve the specificity and reduce the inaccuracy in these methods. We suggest several recently proposed surface chemistries, such as zwitterionic molecules 109-112 could be potent solutions for this issue in nanomaterials associated immunoassays.\nWe also think further research should include the multiplexed detection and automated manipulation. Quantitative assay performed with personalized equipment is also a future goal for colorimetric immunoassay. Recent works suggest that combining colorimetric assays with microfluidic chip could dramatically broaden the applications of nanomaterials-based assays in the future. 113-115 For example, by integrating Au-LSPR substrate with microfluidics and a custom-made optical bench, a high throughput immunoassay was developed for multiplexed detection(Fig. 8a), 116 due to the fact that the bench can precisely control the LSPR substrate so that incident light can irradiate different areas of the chip. By combining immunoassays with barcode patterned microfluidics, an immunoassay for multiple analytes was developed, in this report more than ten individual assays can be integrated in only one chip and the results can be simply read out with a barcode scanner or a smartphone. 117 Another concept was proposed in one case of AuNPs based colorimetric assay for sensing metal ions (Fig. 8b). 118 Images of AuNPs solutions were captured with a smartphone, followed by translating into digital information using image processing\nTable. 2 Advantages and limitation of different nanomaterialassociated colorimetric immunoassays\nApproaches Advantages Limitations Nanomaterials serve as enzyme targets High sensitivity False positive result\nNanomaterials sever as enzymes via chemical reaction\nHigh sensitivity Complicated\noperation\nNanozymes\nEnzyme-free; Cost saving Low sensitivity\nNanomaterials for enrichment\nHigh sensitivity Complicated\noperation; Increased cost\nLFA\nEasy operation Enzyme-free\nLow sensitivity\nRefractive index change based assay Label-free Requirements of\ninstrument; Low sensitivity\n-\nFig. 8 (a) Optical platform for the LSPR immunoassay combining AuNPs coated glasses and microfluidics, this platform is designed to fit commercial UV-Vis spectroscopy. (Reproduced from ref. 116 with permission from The Royal Society of Chemistry). (b) Translation of the colorimetric signal into the digital signal using a smartphone. (Reproduced from ref. 118 with permission from The Royal Society of Chemistry).\nPage 10 of 13Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "Journal Name ARTICLE",
      "text" : "This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 11\nPlease do not adjust margins\nPlease do not adjust margins\nsoftware, thus targets that triggered the color change were quantitatively analyzed. This principle could also be introduced in many other colorimetric immunoassays."
    }, {
      "heading" : "4. Conclusions",
      "text" : "Motivated by the demands in biomedical diagnostics such as improved sensitivity, reduced cost and simplified operation, a number of colorimetric immunoassays that take advantages from the novel properties of nanomaterials were developed. Based on different principles, each of these assays shows outstanding advantages. Some of them that have been used for clinical samples have showed great potential for practical applications. We hope front-line medical staff would benefit from this review in the use of nanomaterials for diagnostics, which would greatly accelerate the research to clinical translation in this field.\nThe continuous evolution of such assays relies on the efforts in instrumental technique and progresses from material, chemical as well as biological sciences. Particularly, we think further research should focus on evaluating the longterm performance of these sensors. We also believe that the original intention, as well as the ultimate goal in this field is to really achieve POC assays for many types of analytes, combining nanomaterials with other formats including portable devices or microfluidics would be the most exciting evolvements in the analytical field for the future years."
    }, {
      "heading" : "Acknowledgements",
      "text" : "We thank the Ministry of Science and Technology of the People's Republic of China (2012AA022703), the National Natural Science Foundation of China (91213305, 51373043, 81361140345), the Chinese Academy of Sciences (XDA09030305), the Ministry of Health (2012ZX10001-008) and the CAS/SAFEA International Partnership Program for Creative Research Teams for financial support."
    }, {
      "heading" : "Notes and references",
      "text" : "1 R. S. Yalow and S. A. Berson, Nature, 1959, 184, 1648-1649. 2 R. M. Lequin, Clin. Chem., 2005, 51, 2415-2418. 3 C. Keegan, C. Smith, F. Ungemach and J. Simpson, Clin.\nChem., 1984, 30, 1025-1025. 4 W. C. W. Chan and S. M. Nie, Science, 1998, 281, 2016-\n2018. 5 T. Sano, C. L. Smith and C. R. Cantor, Science, 1992, 258,\n120-122.\n6 W. W. Zhao, J. J. Xu and H. Y. Chen, Chem. Rev., 2014, 114, 7421-7441. 7 N. Lopez and J. K. Norskov, J. Am. Chem. Soc., 2002, 124, 11262-11263. 8 Y. Zhao, C. Ye, W. Liu, R. Chen and X. Jiang, Angew. Chem., Int. Ed., 2014, 53, 8127-8131. 9 H. He and C. Gao, Sci. China: Chem., 2011, 54, 397-404. 10 J. S. Beveridge, J. R. Stephens and M. E. Williams, Annu.\nRev. Anal. Chem., 2011, 4, 251-273. 11 J. Dobson, Gene Ther., 2006, 13, 283-287.\n12 J. Xie, G. Liu, H. S. Eden, H. Ai and X. Chen, Acc. Chem. Res.,\n2011, 44, 883-892. 13 Y. M. Guo, Z. Wang, H. W. Shao and X. Y. Jiang, Carbon,\n2013, 52, 583-589. 14 Y. M. Guo, Z. Wang, H. W. Shao and X. Y. Jiang, Analyst,\n2012, 137, 301-304. 15 J. P. Xie, Y. G. Zheng and J. Y. Ying, J. Am. Chem. Soc., 2009,\n131, 888-889. 16 D. Loss and D. P. DiVincenzo, Phys. Rev. A: At., Mol., Opt.\nPhys., 1998, 57, 120-126. 17 J. S. Sun, L. Zhang, J. L. Wang, Q. Feng, D. B. Liu, Q. F. Yin, D.\nY. Xu, Y. J. Wei, B. Q. Ding, X. H. Shi and X. Y. Jiang, Adv. Mater., 2015, 27, 1402-1407. 18 Y. Y. Zhao, Y. Tian, Y. Cui, W. W. Liu, W. S. Ma and X. Y. Jiang, J. Am. Chem. Soc., 2010, 132, 12349-12356. 19 Y. Tian, H. M. Wang, Y. Liu, L. N. Mao, W. W. Chen, Z. N.\nZhu, W. W. Liu, W. F. Zheng, Y. Y. Zhao, D. L. Kong, Z. M. Yang, W. Zhang, Y. M. Shao and X. Y. Jiang, Nano Lett., 2014, 14, 1439-1445. 20 Y. G. Sun and Y. N. Xia, Science, 2002, 298, 2176-2179 21 A. K. Khan, R. Rashid, G. Murtaza and A. Zahra, Trop. J.\nPharm. Res,. 2014, 13, 1169-1177. 22 L. Zhang, Q. Feng, J. Wang, J. Sun, X. Shi and X. Jiang,\nAngew. Chem., Int. Ed., 2015, 54, 3952-3956. 23 D. Liu, Z. Wang and X. Jiang, Nanoscale, 2011, 3, 1421-\n1433. 24 D. Y. Yang, X. Niu, Y. Y. Liu, Y. Wang, X. Gu, L. S. Song, R.\nZhao, L. Y. Ma, Y. M. Shao and X. Y. Jiang, Adv. Mater.,\n2008, 20, 4770-4775. 25 W. W. Chen, Y .M. Guo, W. S. Zheng, Y. L. Xianyu, Z. Wang\nand X. Y. Jiang, Chin. J. Inorg. Anal. Chem., 2014, 42, 307- 314. 26 Y. Zhang, Y. Guo, Y. Xianyu, W. Chen, Y. Zhao and X. Jiang, Adv. Mater., 2013, 25, 3802-3819. 27 K. Saha, S. S. Agasti, C. Kim, X. Li and V. M. Rotello, Chem. Rev., 2012, 112, 2739-2779. 28 R. de la Rica and M. M. Stevens, Nat. Nanotechnol., 2012,\n7, 821-824. 29 Y. L. Xianyu, Z. Wang and X. Y. Jiang, ACS Nano., 2014, 8,\n12741-12747.\n30 R. Elghanian, J. J. Storhoff, R. C. Mucic, R. L. Letsinger and C. A. Mirkin, Science, 1997, 277, 1078-1081. 31 J. W. Liu and Y. Lu, J. Am. Chem. Soc., 2003, 125, 6642- 6643. 32 D. B. Liu, W. S. Qu, W. W. Chen, W. Zhang, Z. Wang and X. Y. Jiang, Anal. Chem., 2010, 82, 9606-9610. 33 Y. M. Guo, Z. Wang, W. S. Qu, H. W. Shao and X. Y. Jiang, Biosens. Bioelectron., 2011, 26, 4064-4069. 34 Y. L. Xianyu, J. S. Sun, Y. X. Li, Y. Tian, Z. Wang and X. Y.\nJiang, Nanoscale, 2013, 5, 6303-6306. 35 D. B. Liu, W. W. Chen, J. H. Wei, X. B. Li, Z. Wang and X. Y.\nJiang, Anal. Chem., 2012, 84, 4185-4191. 36 K. Zhu, Y. Zhang, S. He, W. W. Chen, J. Z. Shen, Z. Wang and\nX. Y. Jiang, Anal. Chem., 2012, 84, 4267-4270. 37 D. Pissuwan, C. H. Cortie, S. M. Valenzuela and M. B. Cortie,\nTrends Biotechnol., 2010, 28, 207-213. 38 S. Rana, N. D. B. Le, R. Mout, K. Saha, G. Y. Tonga, R. E. S.\nBain, O. R. Miranda, C. M. Rotello and V. M. Rotello, Nat.\nNanotechnol., 2015, 10, 65-69. 39 Y. J. Zhang, H. Pan, P. F. Zhang, N. N. Gao, Y. Lin, Z. C. Luo,\nP. Li, C. Wang, L. L. Liu, D. W. Pang, L. T. Cai and Y. F. Ma,\nNanoscale, 2013, 5, 5919-5929. 40 D. B. Liu, W. W. Chen, Y. Tian, S. He, W. F. Zheng, J. S. Sun,\nZ. Wang and X. Y. Jiang, Adv. Healthcare Mater., 2012, 1, 90-95. 41 D. B. Liu, Z. T. Wang, A. Jin, X. L. Huang, X. L. Sun, F. Wang, Q. Yan, S. X. Ge, N. S. Xia, G. Niu, G. Liu, A. R. H. Walker and\nX. Y. Chen, Angew. Chem., Int. Ed., 2013, 52, 14065-14069.\nPage 11 of 13 Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "ARTICLE Journal Name",
      "text" : "12 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx\nPlease do not adjust margins\nPlease do not adjust margins\n42 Y. Zhou, S. X. Wang, K. Zhang and X. Y. Jiang, Angew.\nChem., Int. Ed., 2008, 47, 7454-7456. 43 L. Rodriguez-Lorenzo, R. de la Rica, R. A. Alvarez-Puebla, L.\nM. Liz-Marzan and M. M. Stevens, Nat. Mater., 2012, 11, 604-607. 44 D. B. Liu, J. Yang, H. F. Wang, Z. L. Wang, X. L. Huang, Z. T. Wang, G. Niu, A. R. H. Walker and X. Y. Chen, Anal. Chem.,\n2014, 86, 5800-5806. 45 X. J. Yang, Y. B. Yu and Z. Q. Gao, ACS Nano, 2014, 8, 4902-\n4907.\n46 J. J. Liang, C. Z. Yao, X. Q. Li, Z. Wu, C. H. Huang, Q. Q. Fu, C. F. Lan, D. L. Cao and Y. Tang, Biosens. Bioelectron., 2015, 69, 128-134. 47 C. Parolo, A. de la Escosura-Muniz and A. Merkoci, Biosens. Bioelectron., 2013, 40, 412-416. 48 D. H. Choi, S. K. Lee, Y. K. Oh, B. W. Bae, S. D. Lee, S. Kim, Y.\nB. Shin and M. G. Kim, Biosens. Bioelectron., 2010, 25, 1999–2002. 49 M. H. Chen, Z. B. Yu, D. F. Liu, T. Peng, K. Liu, S. Y. Wang, Y.\nH. Xiong, H. Wei, H. Y. Xu and W. H. Lai, Anal. Chim. Acta., 2015, 876, 71-76. 50 S. Y. Hong, Y. M. Park, Y. H. Jang, B. H. Min and H. C. Yoon,\nBioChip J., 2012, 6, 213-220. 51 X. Mao, Y. Ma, A. Zhang, L. Zhang, L. Zeng and G. Liu, Anal.\nChem., 2009, 81, 1660-1668. 52 J. Hu, S. Wang, L. Wang, F. Li, B. Pingguan-Murphy, T. J. Lu\nand F. Xu, Biosens. Bioelectron., 2014, 54, 585-597. 53 A. J. Haes and R. P. Van Duyne, Anal. Chim. Acta., 2004,\n379, 920-930. 54 M. P. Raphael, J. A. Christodoulides, S. P. Mulvaney, M. M.\nMiller, J. P. Long and J. M. Byers, Anal. Chem., 2012, 84, 1367-1373. 55 N. Nath and A. Chilkoti, Anal. Chem., 2002, 74, 504-509. 56 K. S. Lee and M. A. El-Sayed, J. Phys. Chem. B, 2006, 110,\n19220-19225. 57 C. L. Nehl, H. W. Liao and J. H. Hafner, Nano Lett., 2006, 6,\n683-688.\n58 Pastoriza-Santos, A. Sanchez-Iglesias, F. J. G. de Abajo and L. M. Liz-Marzan, Adv. Funct. Mater., 2007, 17, 1443-1450. 59 B. Sepulveda, P. C. Angelome, L. M. Lechuga and L. M. Liz-\nMarzan, Nano Today, 2009, 4, 244-251. 60 S. M. Marinakos, S. Chen and A. Chilkoti, Anal. Chem, 2007,\n79, 5278-5283. 61 Y. Wang, W. P. Qian, Y. Tan and S. H. Ding, Biosens.\nBioelectron., 2008, 23, 1166–1170. 62 S. Chen, M. Svedendahl, R. P. Van Duyne and M. Kall, Nano\nLett., 2011, 11, 1826-1830. 63 P. Chen and B. Liedberg, Anal. Chem., 2014, 86, 7399-7405. 64 J. Yamamichi, T. Ojima, M. Iida, K. Yurugi, T. Imamura, E.\nAshihara, S. Kimura and T. Maekawa, Anal. Bioanal. Chem., 2014, 406, 4527-4533. 65 C. Xue, Z. Li and C. A. Mirkin, Small, 2005, 1, 513-516. 66 S. K. Smoukov, K. J. M. Bishop, B. Kowalczyk, A. M. Kalsin\nand B. A. Grzybowski, J. Am. Chem. Soc., 2007, 129, 15623- 15630. 67 C. L. Haynes and R. P. Van Duyne, J. Phys. Chem. B, 2001, 105, 5599-5611. 68 J. N. Anker, W. P. Hall, O. Lyandres, N. C. Shah, J. Zhao and\nR. P. Van Duyne, Nat. Mater., 2008, 7, 442-453. 69 T. R. Jensen, M. D. Malinsky, C. L. Haynes and R. P. Van\nDuyne, J. Phys. Chem. B, 2000, 104, 10549-10556. 70 C. Y. Hsu, J. W. Huang, S. Gwo and K. J. Lin,\nNanotechnology, 2010, 21, 035302. 71 C. Y. Hsu, J. W. Huang and K. J. Lin, Chem. Commun., 2011,\n47, 872-874. 72 L. H. Guo, J. A. Jackman, H. H. Yang, P. Chen, N. J. Cho and\nD. H. Kim, Nano Today, 2015, 10, 213-239.\n73 H. Y. Wang, L. X. Wu and B. M. Reinhard, ACS Nano, 2012,\n6, 7122-7132. 74 L. Shi, C. Jing, W. Ma, D. W. Li, J. E. Halls, F. Marken and Y.\nT. Long, Angew. Chem., Int. Ed., 2013, 52, 6011-6014. 75 C. Sonnichsen, B. M. Reinhard, J. Liphardt and A. P.\nAlivisatos, Nat. Biotechnol., 2005, 23, 741-745. 76 K. Li, W. W. Qin, F. Li, X. C. Zhao, B. W. Jiang, K. Wang, S. H.\nDeng, C. H. Fan and D. Li, Angew. Chem., Int. Ed., 2013, 52, 11542-11545. 77 P. M. Kosaka, V. Pini, J. J. Ruz, R. A. da Silva, M. U.\nGonzalez, D. Ramos, M. Calleja and J. Tamayo, Nat. Nanotechnol., 2014, 9, 1047-1053. 78 L. H. Guo, Y. J. Huang, Y. Kikutani, Y. Tanaka, T. Kitamori\nand D. H. Kim, Lab Chip, 2011, 11, 3299-3304. 79 W. S. Qu, Y. Y. Liu, D. B. Liu, Z. Wang and X. Y. Jiang, Angew.\nChem., Int. Ed., 2011, 50, 3442-3445. 80 C. H. Lu, Y. W. Wang, S. L. Ye, G. N. Chen and H. H. Yang,\nNPG Asia Mater., 2012, 4, e10. 81 F. Manea, F. B. Houillon, L. Pasquato and P. Scrimin,\nAngew. Chem. Int. Ed., 2004, 43, 6165-6169. 82 L. Pasquato, P. Pengo and P. Scrimin, Supramol. Chem.,\n2005, 17, 163-171. 83 L. Z. Gao, J. Zhuang, L. Nie, J. B. Zhang, Y. Zhang, N. Gu, T.\nH. Wang, J. Feng, D. L. Yang, S. Perrett and X. Yan, Nat. Nanotechnol., 2007, 2, 577-583. 84 J. B. Liu, X. N. Hu, S. Hou, T. Wen, W. Q. Liu, X. Zhu, J. J. Yin and X. C. Wu, Sens. Actuators, B, 2012, 166–167, 708–714. 85 X. X. Wang, Q. Wu, Z. Shan and Q. M. Huang, Biosens.\nBioelectron., 2011, 26, 3614–3619. 86 J. S. Mu, Y. Wang, M. Zhao and L. Zhang, Chem. Commun.,\n2012, 48, 2540–2542. 87 Y. J. Song, X. H. Wang, C. Zhao, K. G. Qu, J. S. Ren and X. G.\nQu, Chem.–Eur. J., 2010, 16, 3617–3621. 88 W. Chen, J. Chen, Y. B. Feng, L. Hong, Q. Y. Chen, L. F. Wu,\nX. H. Lin and X. H. Xia, Analyst, 2012, 137, 1706–1712. 89 Y. Wan, P. Qi, D. Zhang, J. J. Wu and Y. Wang, Biosens.\nBioelectron., 2012, 33, 69–74. 90 X. Q. Zhang, S. W. Gong, Y. Zhang, T. Yang, C. Y. Wang and\nN. Gu, J. Mater. Chem., 2010, 20, 5110–5116. 91 F. L. Qu, T. Li and M. H. Yang, Biosens. Bioelectron., 2011,\n26, 3927–3931. 92 Y. Guo, L. Deng, J. Li, S. Guo, E. Wang and S. Dong, ACS\nNano, 2011, 5, 1282-1290. 93 A. Asati, C. Kaittanis, S. Santra and J. M. Perez, Anal. Chem.,\n2011, 83, 2547-2553. 94 H. Wei and E. K. Wang, Chem. Soc. Rev., 2013, 42, 6060-\n6093. 95 S. J. Guo and E. K. Wang, Nano Today, 2011, 6, 240-264. 96 Y. J. Song, K. G. Qu, C. Zhao, J. S. Ren and X. G. Qu, Adv.\nMater., 2010, 22, 2206–2210 97 N. Wang, L. H. Zhu, D. L. Wang, M. Q. Wang, Z. F. Lin and H.\nQ. Tang, Ultrason. Sonochem., 2010, 17, 526–533 98 J. Mu, Y. Wang, M. Zhao and L. Zhang, Chem. Commun.,\n2012, 48, 2540-2542. 99 Z. F. Wang, X. Yang, J. J. Yang, Y. Y. Jiang and N. Y. He, Anal.\nChim. Acta., 2015, 862, 53-63. 100 Y. Chen, Y. Xianyu, Y. Wang, X. Zhang, R. Cha, J. Sun and X.\nJiang, ACS Nano, 2015, 9, 3184-3191. 101 Y. Pan, X. Du, F. Zhao and B. Xu, Chem. Soc. Rev., 2012, 41,\n2912-2942. 102 P.C. Lin, M.C. Tseng, A.K. Su, Y.J. Chen and C.C. Lin, Anal.\nChem., 2007, 79, 3401-3408. 103 L. Xu, H. Yu, S.J. Han, S. Osterfeld, R. L. White, N. Pourmand\nand S. X. Wang, IEEE Trans. Magn., 2008, 44, 3989-3991. 104 E. Katz, R. Baron and I. Willner, J. Am. Chem. Soc., 2005,\n127, 4060-4070. 105 J. Xie, J. Huang, X. Li, S. Sun and X. Chen, Curr. Med. Chem.,\n2009, 16, 1278-1294.\nPage 12 of 13Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    }, {
      "heading" : "Journal Name ARTICLE",
      "text" : "This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 13\nPlease do not adjust margins\nPlease do not adjust margins\n106 L. Tang, J. Casas and M. Venkataramasubramani, Anal.\nChem., 2012, 85, 1431–1439 107 M. Y. Liu, C. P. Jia, Q. H. Jin, X. H. Lou, S. H. Yao, J. Q. Xiang\nand J. L. Zhao, Talanta, 2010, 81, 1625-1629. 108 Z. Q. Gao, M. D. Xu, L. Hou, G. N. Chen and D. P. Tang, Anal.\nChem., 2013, 85, 6945-6952. 109 R. E. Holmlin, X. X. Chen, R. G. Chapman, S. Takayama and\nG. M. Whitesides, Langmuir, 2001, 17, 2841-2850. 110 X. S. Liu, H. Y. Huang, Q. Jin and J. Ji, Langmuir, 2011, 27,\n5242-5251.\n111 X. Jiang, D. A. Bruzewicz, M. M. Thant and G. M. Whitesides, Anal. Chem., 2004, 76, 6116-6121 112 S. Chen, J. Zheng, L. Li and S. Jiang, J. Am. Chem. Soc., 2005,\n127, 14473-14478. 113 Y. Liu, J. Yu, W. Chen, D. Liu, Z. Wang and X. Jiang, Chin. J.\nChem., 2012, 30, 2047-2051. 114 J. Sun, Y. Xianyu and X. Jiang, Chem. Soc. Rev., 2014, 43,\n6239-6253. 115 Z. Zhu, Z. Guan, S. Jia, Z. Lei, S. Lin, H. Zhang, Y. Ma, Z. Q.\nTian and C. J. Yang, Angew. Chem. Int. Ed., 2014, 53, 12503- 12507. 116 Y. Zhang, Y. F. Tang, Y. H. Hsieh, C. Y. Hsu, J. Z. Xi, K. J. Lin\nand X. Y. Jiang, Lab Chip, 2012, 12, 3012-3015. 117 Y. Zhang, J. S. Sun, Y. Zou, W. W. Chen, W. Zhang, J. J. Xi\nand X. Y. Jiang, Anal. Chem., 2015, 87, 900-906. 118 W. W. Chen, F. J. Cao, W. S. Zheng, Y. Tian, Y. L. Xianyu, P.\nXu, W. Zhang, Z. Wang, K. Deng and X. Y. Jiang, Nanoscale, 2015, 7, 2042-2049.\nPage 13 of 13 Analyst\n1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60\nA na\nly st\nA cc\nep te\nd M\nan us\ncr ip\nt\nPu bl\nis he\nd on\n1 3\nJa nu\nar y\n20 16\n. D ow\nnl oa\nde d\nby M\nid dl\ne E\nas t T\nec hn\nic al\nU ni\nve rs\nity (\nO rt\na D\nog u\nT ek\nni k\nU )\non 1\n3/ 01\n/2 01\n6 14\n:1 0:\n30 .\nView Article Online DOI: 10.1039/C5AN02222C"
    } ],
    "references" : [ ],
    "referenceMentions" : [ ],
    "year" : 2016,
    "abstractText" : "Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. Accepted Manuscript Analyst",
    "creator" : "Aspose Ltd."
  }
}